Mablink Bioscience receives €31M series A funding for ADC pipeline
French biotech company Mablink Bioscience has raised €31 million ($30.3 million) in series A funding…
October 14, 2022 - 2 minutes
Antibody-drug conjugates
Check out the latest antibody-drug conjugate news. This section covers the latest updates on approvals, regulations, deals, and antibody–drug conjugate (ADC) technology.
Trial starts for treatment of warm autoimmune hemolytic anemia
China-based Hutchmed has started a phase 2/3 trial of sovleplenib in adults with a disorder…
October 10, 2022 - 2 minutes
Araris Biotech closes $24M financing round for ADCs
Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate (ADC)-linker technology, today announced the…
October 5, 2022 - 2 minutes
Pheon Therapeutics launches with $68M in series A funding for treatment of solid tumors
Pheon Therapeutics launched today (September 28) following the closing of a $68 million series A…
September 28, 2022 - 3 minutes
Cartography Biosciences unearths cancer immunotherapy targets
Despite its meteoric growth in the last twenty years, cancer immunotherapy research is hamstrung by…
September 22, 2022 - 5 minutes
Synaffix and Emergence in $360M technology platform deal to develop ADCs
Dutch biotech Synaffix B.V. and German Emergence Therapeutics announced today (September 6) they have entered…
September 6, 2022 - 2 minutes
CSL gets positive results for preventive treatment in patients with hereditary angioedema
Hereditary angioedema (HAE), a condition that causes recurrent attacks of severe swelling, could be prevented…
August 18, 2022 - 3 minutes
Mersana Therapeutics announces collaboration with GSK for the co-development of cancer treatment
A global collaboration was announced today (August 9) between Mersana Therapeutics Inc and GSK plc…
August 9, 2022 - 3 minutes
Formulations of Arecor Therapeutics’ drug to treat inflammatory diseases granted patents
Formulations of a drug that can help a number of inflammatory diseases including rheumatoid arthritis…
August 9, 2022 - 3 minutes
Patients with advanced cancer set to benefit from ProfoundBio’s new drug
Patients with ovarian, endometrial, breast, non-small cell lung cancers and mesothelioma could benefit from an…
August 3, 2022 - 2 minutes
Boston startup bags $40M Series A to smash preclinical bottlenecks
The U.S. company Manifold Bio has raised $40 million in a Series A round to…
July 14, 2022 - 3 minutes
Legochem Bioscience signs agreement with Glycotope to develop cancer drug
A company from South Korea has signed a research collaboration and license agreement with a…
July 12, 2022 - 3 minutes
